Oncotarget AI for Improved PET/CT Attenuation Correction in Prostate Cancer Imaging In this new study, researchers investigated an artificial intelligence (AI) tool that produces attenuation-corrected PET... read more July 11, 2024
Oncotarget Bacterial Therapy Revelations in Prostate Cancer Researchers reveal their positive findings from a 2020 study on a strain of Salmonella... read more November 4, 2021
Oncotarget Behind the Study: Evaluations in TRAMP Prostate Cancer Model Dr. Yves Chabu from the Department of Biological Sciences at the University of Missouri describes... read more September 20, 2021
Oncotarget Oncotarget Testimonial: Dr. Yves Chabu Below is a transcript of the testimonial by Dr. Yves... read more September 17, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue #16 Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more August 3, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue #7 Read short summaries of the latest research literature published by Oncotarget.Origin: Quebec, CanadaInstitutions:&... read more March 30, 2021
Oncotarget Behind the Study: Melatonin and Prostate Cancer Professor Vladimir Anisimov details the study he co-authored in an Oncotarget publication, titled: “Melatonin increases... read more March 11, 2021
Oncotarget Symmetrically Dividing Prostate Cancer Cells Drive Exponential Growth Researchers in this study use scaling analysis to show that, in patients with prostate cancer... read more January 5, 2021
Oncotarget Novel MicroRNA Identified as Prostate Cancer Biomarker Researchers based out of the United States identified a new microRNA as a key regulator... read more December 22, 2020
Oncotarget Trending with Impact: Melatonin’s Anticancer Effect in Prostate Cancer A retrospective study from Russia demonstrates the anticancer effects of melatonin in poor-prognosis prostate cancer... read more December 17, 2020